Literature DB >> 12137097

Reduced baroreceptor reflex sensitivity and increased blood pressure variability at 2400 m simulated cabin altitude.

Knut Sevre1, Bjørn Bendz, Morten Rostrup.   

Abstract

In a hypobaric chamber nine healthy volunteers were exposed to an atmospheric pressure corresponding to 2400 m above sea level. This is similar to the lowest air pressure encountered inside pressurized commercial airplanes. Heart rate and blood pressure were monitored beat-to-beat in the supine position with a non-invasive device. Blood pressure variability and heart rate variability were measured in the mid-frequency band; subsequently, baroreceptor reflex sensitivity (BRS) was calculated with the transfer-function method. Compared with baseline, there were reduced BRS and increased blood pressure variability at 2400 m (16.5 +/- 3.1 vs. 13.2 +/- 2.0 ms x mm Hg(-1) and 5.4 +/- 1.3 vs. 8.2 +/- 1.1 mm Hg, respectively; p < 0.05). We conclude that autonomic cardiovascular control was disturbed during acute exposure to an air pressure corresponding to 2400 m.

Entities:  

Mesh:

Year:  2002        PMID: 12137097

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  3 in total

1.  Interaction of chemoreceptor and baroreceptor reflexes by hypoxia and hypercapnia - a mechanism for promoting hypertension in obstructive sleep apnoea.

Authors:  V L Cooper; S B Pearson; C M Bowker; M W Elliott; R Hainsworth
Journal:  J Physiol       Date:  2005-08-18       Impact factor: 5.182

2.  Blood pressure response to exposure to moderate altitude in patients with COPD.

Authors:  Esther I Schwarz; Tsogyal D Latshang; Michael Furian; Deborah Flück; Sebastian Segitz; Severine Müller-Mottet; Silvia Ulrich; Konrad E Bloch; Malcolm Kohler
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-03-14

3.  Interactions of the human cardiopulmonary, hormonal and body fluid systems in parabolic flight.

Authors:  U Limper; P Gauger; P Beck; F Krainski; F May; L E J Beck
Journal:  Eur J Appl Physiol       Date:  2014-03-13       Impact factor: 3.078

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.